Country for PR: United Kingdom
Contributor: PR Newswire Europe
Friday, April 21 2017 - 06:51
INSIGHTEC: First Patient with Benign Brain Tumor has Focused Ultrasound Procedure at Nicklaus Children’s Hospital
HAIFA, Israel, Apr. 21, 2017, /PRNewswire-AsiaNet/ --

    INSIGHTEC [ ] congratulates Nicklaus Children's 
Hospital [ ], part of the Miami 
Children's Health System, for performing the first focused ultrasound procedure 
on a 21-year old patient suffering seizures associated with a benign 
hypothalamic hamartoma brain tumor.

    Hypothalamic hamartoma is a rare, benign (non-cancerous) brain tumor that 
can cause different types of seizures, cognitive problems or other symptoms. 
While the exact number of people with hypothalamic hamartomas is not known, it 
is estimated to occur in one out of 200,000 children and teenagers worldwide.

    The medical team at Nicklaus Children's Hospital is performing MR-guided 
Focused Ultrasound (MRgFUS) using the Exablate Neuro system as part of an 
FDA-approved feasibility study. The goal of the pilot study is to gather the 
preliminary safety profile of this incisionless ablative treatment for benign 
centrally-located intracranial tumors in pediatric and young adults. The MRgFUS 
procedure involves applying high energy ultrasound waves guided by magnetic 
resonance imaging (MRI) to heat and ablate the target tumor, without impacting 
the scalp, skull or surrounding healthy brain tissue.

    The medical and research team at Nicklaus Children's is led by Dr. John 
Ragheb, Director of Division of Neurosurgery; Dr. Travis Tierney, Principal 
Investigator; Dr. Ian Miller, Director of Epilepsy Program; Dr. Sanjiv Bhatia, 
neurosurgeon; Dr. Nolan Altman, Director of Radiology; Dr. Prasanna Jayakar, 
Chairman of the Brain Institute at Nicklaus Children's Hospital; and Dr. 
Jennifer McCafferty, Director of Research, Miami Children's Research Institute.

    "This breakthrough first procedure sets the stage for us to provide 
incisionless surgery for young patients with benign centrally-located brain 
tumors. Our team is encouraged by the potential of focused ultrasound 
technology to positively impact lives," said Prasanna Jayakar, MD, PhD, 
Chairman of the Brain Institute at Nicklaus Children's Hospital.

    "We applaud the team at Nicklaus Children's for their commitment to 
treating children with various brain conditions. Their pioneering research with 
our MRgFUS technology offers hope that significant groups of pediatric patients 
will be able to undergo treatment without any surgical incision, minimizing or 
eliminating the risk of infection or other surgical complications," said 
Maurice R. Ferre MD, CEO and Chairman of INSIGHTEC.

    "The needs of pediatric patients emphasize some of the important advantages 
of focused ultrasound. It is incisionless, avoids ionizing radiation, offers 
less risk of infection and disruption of adjacent normal tissue than surgery, 
and patients often return to normal activities within days," says Focused 
Ultrasound Foundation's Chief Medical Officer, Tim Meakem, MD.  "These benefits 
are especially important in neurosurgery, and researchers around the world are 
investigating other areas where this innovative care could improve outcomes for 
patients of all ages. The Foundation congratulates the entire team of Nicklaus 
Children's Hospital and INSIGHTEC for this breakthrough achievement."

    Funds for the study have been provided by the Focused Ultrasound 
Foundation. Regulatory sponsorship has been provided by INSIGHTEC.

    To read the Nicklaus Children's Hospital press release, please click here

    About INSIGHTEC 

    INSIGHTEC is the world leader and innovator of MR-guided Focused Ultrasound 
(MRgFUS). The company's non-invasive therapy platforms, Exablate and Exablate 
Neuro, are proven technology based on sound clinical evidence for treating 
essential tremor, painful bone metastases and uterine fibroids. The company is 
dedicated to improving patient lives by collaborating with physicians, medical 
institutions, academic researchers and regulatory bodies around the world. For 
more information, please visit:

    About Nicklaus Children's Hospital 

    Founded in 1950 by Variety Clubs International, Nicklaus Children's 
Hospital - part of Miami Children's Health System - is South Florida's only 
licensed specialty hospital exclusively for children, with more than 740 
attending physicians and over 220 pediatric subspecialists. The 289-bed 
hospital is renowned for excellence in all aspects of pediatric medicine with 
several specialty programs routinely ranked among the best in the nation by 
U.S. News & World Report. The hospital is also home to the largest pediatric
teaching program in the southeastern United States and has been designated an 
American Nurses Credentialing Center (ANCC) Magnet facility, the nursing 
profession's most prestigious institutional honor. For more information, please 

    About the Focused Ultrasound Foundation 

    The Focused Ultrasound Foundation was created to improve the lives of 
millions of people worldwide by accelerating the development of focused 
ultrasound, an early-stage, noninvasive, therapeutic technology with the 
potential to transform the treatment of many serious medical disorders. The 
Foundation works to clear the path to global adoption by coordinating and 
funding research, fostering collaboration, and building awareness among
patients and professionals. It is dedicated to ensuring that focused ultrasound 
finds its place as a mainstream therapy for a range of conditions within years, 
not decades. Since its establishment in 2006, the Foundation has become the 
largest non-governmental source of funding for focused ultrasound research. 
More information can be found at
    Media Contact: 
    Carolyn Tiernan 
    Red Lorry Yellow Lorry for INSIGHTEC 
    +1(617)237-0922 x 411